Francesco Perrone

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" — Italy

Economics, Econometrics and Finance · Social Sciences

54h-index11.5kcitations373works3.22yr avg

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Health Systems, Economic Evaluations, Quality of Life(69), Ovarian cancer diagnosis and treatment(58), Lung Cancer Treatments and Mutations(56), Economic and Financial Impacts of Cancer(49), Lung Cancer Research Studies(35)

Publications369 total

Late endocrine-metabolic complications in survivors of young adult and adult-onset cancers: comprehensive evaluation and strategies for management. An Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical review

Journal of Endocrinological Investigation·2025Open Access

Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial

ESMO Open·2025Open Access

Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial

npj Precision Oncology·2025Open Access

Investigational sites requirements according to trial complexity and intervention level under EU Regulation No. 536/2014

Journal of Cancer Policy·2025

Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica

Tumori Journal·2025

The Other Side of the Same Coin: Beyond the Coding Region in Amyotrophic Lateral Sclerosis

Pharmaceuticals·2025Open Access

Longitudinal validation of the PROFFIT questionnaire to assess financial toxicity in cancer patients

Journal of Cancer Policy·2025Open Access

OA12.02 CCTG IND227, a Randomized Trial of Chemotherapy + Pembrolizumab in Advanced Pleural Mesothelioma: Updated Analyses

Journal of Thoracic Oncology·2025

WITHDRAWN: 2726P Real-world versus trial populations in metastatic soft tissue sarcomas: A comparative analysis of AIFA monitoring registries and clinical trials of trabectedin and pazopanib

Annals of Oncology·2025

Using CCDC6 immunostaining in conjunction with the RAD51 HRD assay as a novel approach to expand PARPi treatment eligibility in HGSOC patients

2025Open Access

Facing antimicrobial resistance in cancer care: what the AIOM survey tells us about oncologists’ awareness

JAC-Antimicrobial Resistance·2025Open Access

Cancer Awareness Among People Living with HIV (PLWH): Insights from an Italian Survey of Oncologists and Infectious Disease Specialists

HIV/AIDS - Research and Palliative Care·2025Open Access

Patient-reported outcomes (PROs) in clinical trials and in clinical practice: report from the XXI national conference of the Italian Association of Medical Oncology (AIOM)

5 cited

BMJ Oncology·2025· 5 citedOpen Access

Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatments

Journal of Translational Medicine·2025Open Access

21P Multi-omic characterization of CDK4/6 inhibitor resistance: The UNDERSTAND study

ESMO Open·2025Open Access

Telemedicine for Outpatients: A Case Study of the First Experience with Diabetic Patients in the Local Health Authority of Modena.

PubMed·2025Open Access

Press releases of industry-sponsored clinical trials in oncology: Characteristics, timing and financial impact

2 cited

Journal of Cancer Policy·2025· 2 citedOpen Access

Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)

2 cited

Cancer Immunology Immunotherapy·2025· 2 citedOpen Access

LBA3: Sites of relapse and subsequent therapy in the BR.31 phase III study of durvalumab vs placebo in resected stage IB-IIIA NSCLC

2 cited

Journal of Thoracic Oncology·2025· 2 citedOpen Access

page 1 of 19Next →

Frequent Co-authors

Ciro Gallo(36), Massimo Di Maïo(28), Maria Carmela Piccirillo(18), Cesare Gridelli(17), Alessandro Morabito(16), Gennaro Daniele(14), Sandro Pignata(12), Saverio Cinieri(11), Vittorio Gebbia(10), Paolo Chiodini(9), Sabino De Placido(9), Giovanni Scambia(9), Nicola Normanno(9), Fortunato Ciardiello(8), A. De Matteis(8), Rossella Lauria(8), Carmela Pisano(8), Domenica Lorusso(8), Francesco Nuzzo(6), Simona Signoriello(6)